Asthma Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Anti Inflammatory, Bronchodilators, Combination Therapy), By Product (Inhalers, Dry Powder, Metered Dose, Soft Mist, Nebulizers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Asthma Therapeutics Market Size Analysis
    1. Introduction
    2. Asthma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Anti Inflammatory
      2. Bronchodilators
      3. Combination Therapy
    3. Asthma Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Inhalers
      2. Dry Powder
      3. Metered Dose
      4. Soft Mist
      5. Nebulizers
      6. Others
  7. North America Asthma Therapeutics Market Size Analysis
    1. Introduction
    2. Asthma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Anti Inflammatory
      2. Bronchodilators
      3. Combination Therapy
    3. Asthma Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Inhalers
      2. Dry Powder
      3. Metered Dose
      4. Soft Mist
      5. Nebulizers
      6. Others
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
  8. Europe Asthma Therapeutics Market Size Analysis
    1. Introduction
    2. Asthma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Anti Inflammatory
      2. Bronchodilators
      3. Combination Therapy
    3. Asthma Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Inhalers
      2. Dry Powder
      3. Metered Dose
      4. Soft Mist
      5. Nebulizers
      6. Others
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    6. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
  9. APAC Asthma Therapeutics Market Size Analysis
    1. Introduction
    2. Asthma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Anti Inflammatory
      2. Bronchodilators
      3. Combination Therapy
    3. Asthma Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Inhalers
      2. Dry Powder
      3. Metered Dose
      4. Soft Mist
      5. Nebulizers
      6. Others
    4. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    7. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
  10. Middle East and Africa Asthma Therapeutics Market Size Analysis
    1. Introduction
    2. Asthma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Anti Inflammatory
      2. Bronchodilators
      3. Combination Therapy
    3. Asthma Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Inhalers
      2. Dry Powder
      3. Metered Dose
      4. Soft Mist
      5. Nebulizers
      6. Others
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
  11. LATAM Asthma Therapeutics Market Size Analysis
    1. Introduction
    2. Asthma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Anti Inflammatory
      2. Bronchodilators
      3. Combination Therapy
    3. Asthma Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Inhalers
      2. Dry Powder
      3. Metered Dose
      4. Soft Mist
      5. Nebulizers
      6. Others
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti Inflammatory
        2. Bronchodilators
        3. Combination Therapy
      3. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Dry Powder
        3. Metered Dose
        4. Soft Mist
        5. Nebulizers
        6. Others
  12. Competitive Landscape
    1. Asthma Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. AstraZeneca
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Boehringer Ingelheim International GmbH
    3. Chiesi Farmaceutici S.p.A.
    4. Cipla Limited
    5. Hoffmann-La Roche Ltd.
    6. GSK plc
    7. Merck & Co., Inc.
    8. Mitsubishi Tanabe Pharma
    9. Novartis AG
    10. Pfizer Inc.
    11. Sanofi
    12. Sun Pharmaceutical Industries Ltd.
    13. Teva Pharmaceutical Industries Ltd.
    14. Viatris Inc.
    15. Covis Pharma Group
    16. Astellas Pharma Inc.
    17. Vertex Pharmaceuticals Incorporated
    18. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

We are featured on: